Has cognitive behavioural therapy for psychosis been oversold?

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  McKenna, Peter ^a   Kingdon, David ^b  

^a FIDMAG GERMANES HOSPITALÀRIES RESEARCH FOUNDATION   (Spain)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL STUDY; COGNITIVE THERAPY; DELUSION; DISEASE SEVERITY; MENTAL HEALTH SERVICE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; THERAPY EFFECT;

ANTIPSYCHOTIC AGENTS; COGNITIVE THERAPY; HUMANS; META-ANALYSIS AS TOPIC; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84897552868     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g2295     Document Type: Article

References (20)

1. Kuipers E, Garety P, Fowler D, Dunn G, Bebbington P, Freeman D, et al. London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: effects of the treatment phase. Br J Psychiatry 1997;171:319-27.
2. Turkington D, Kingdon D, Turner T. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. Br J Psychiatry 2002;180:523-7.
3. Van der Gaag M, Stant AD, Wolters KJ, Buskens E, Wiersma D. Cognitive-behavioural therapy for persistent and recurrent psychosis in people with schizophrenia-spectrum disorder: cost-effectiveness analysis. Br J Psychiatry 2011;198(supp 1):59-65.
4. NICE. Schizophrenia: core interventions in the treatment and management of schizophrenia in adults in primary and secondary care (update). NICE, 2009.
5. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Statistics 2001;29:1165-88.
6. Jones C, Hacker D, Cormac I, Meaden A, Irving CB. Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database Syst Rev 2012;4:CD008712.
7. Turner DT, van der Gaag M, Karyotaki E, Cuijpers P. Psychological interventions for psychosis: a meta-analysis of comparative outcome studies. Am J Psychiatry 2014 [Epub ahead of print].
8. Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry 2014;204:20-9.
9. Balter M. Talking back to madness. Science 2014;343(6176):1190-3.
10. Kingdon D, Wykes T. Increased funding needed for mental health research. BMJ 2013;346:f402.
11. Bentall RP, Rowse G, Shryane N, Kinderman P, Howard R, Blackwood N, et al.The cognitive and affective structure of paranoid delusions: a transdiagnostic investigation of patients with schizophrenia spectrum disorders and depression. Arch Gen Psychiatry 2009;66:236-47.
12. Reininghaus U, Craig TK, Fisher HL, Hutchinson G, Fearon P, Morgan K, et al. Ethnic identity, perceptions of disadvantage, and psychosis: findings from the ÆSOP study. Schizophr Res 2010;124:43-8.
13. Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, et al. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry 2000;57:165-72.
14. Turkington D, Sensky T, Scott J, Barnes TR, Nur U, Siddle R, et al. A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: a five-year follow-up. Schizophr Res 2008;98:1-7.
15. Barrowclough C, Haddock G, Wykes T, Beardmore R, Conrod P, Craig T, et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ 2010;341:c6325.
16. Tarrier N, Lewis S, Haddock G, Bentall R, Drake R, Kinderman P, et al. Cognitive-behavioural therapy in first-episode and early schizophrenia. 18-month follow-up of a randomised controlled trial. Br J Psychiatry 2004;184:231-9.
17. Moncrieff J. Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination. Br J Psychiatry 2003;183:161-6.
18. Gaebel W, Riesbeck M, Wobrock T. Schizophrenia guidelines across the world: a selective review and comparison. Int Rev Psychiatry 2011;23:379-87.
19. Morrison AP, Turkington D, Pyle M, Spencer H, Brabban A, Dunn G, et al. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Lancet 2014 Feb 6. doi: 10.1016/S0140-6736(13)62246-1.
20. Kingdon D. A golden age of discovery. Br J Psychiatry 2013;202:394-5.